The development of effective medical treatments relies heavily on the availability of high-quality chemical intermediates. Among these, Bupivacaine Hydrochloride, identified by its CAS number 14252-80-3, is a crucial compound extensively used in the pharmaceutical industry. This article highlights the essential aspects of Bupivacaine HCl as a chemical intermediate, detailing its properties and its indispensable role in the creation of local anesthetic drugs.

Bupivacaine Hydrochloride is typically presented as a white crystalline powder, a characteristic that is important for its handling and formulation in pharmaceutical manufacturing. Its molecular formula is C18H28N2O.ClH, with a molecular weight of 324.89. These precise chemical specifications are vital for ensuring the correct synthesis and efficacy of the final anesthetic products. The compound's high purity, often specified at over 99%, is a critical attribute that pharmaceutical manufacturers demand to guarantee the safety and potency of their formulations.

As a pharmaceutical intermediate for anesthesia, Bupivacaine HCl is the foundational building block for anesthetics used in a variety of medical procedures. Its primary function is to provide prolonged local anesthesia, blocking nerve signals to manage pain effectively. This makes it a preferred ingredient for applications such as peripheral nerve blocks, epidural anesthesia, and local infiltration anesthesia, which are essential in surgical settings, dentistry, and labor analgesia.

The production of Bupivacaine Hydrochloride involves sophisticated chemical processes to achieve the required purity and quality. Pharmaceutical companies rely on suppliers who maintain rigorous quality control measures, including adherence to GMP and ISO standards. This commitment ensures that the intermediate consistently meets the exacting requirements of the pharmaceutical industry. For example, understanding the Bupivacaine HCl purity 99% specification helps manufacturers select intermediates that will lead to drug products with predictable performance and minimal side effects.

The unique properties of Bupivacaine HCl, such as its ability to provide extended anesthesia, make it an invaluable component in pain management strategies. By understanding the chemical nature and sourcing requirements of this vital intermediate, pharmaceutical manufacturers can ensure the consistent production of safe and effective anesthetic solutions. The reliability of the supply chain, starting from high-quality chemical intermediates like Bupivacaine Hydrochloride, directly translates to improved patient care and better outcomes.

In conclusion, Bupivacaine Hydrochloride (CAS 14252-80-3) represents a critical link in the chain of producing advanced local anesthetics. Its specified physical and chemical properties, particularly its high purity, are fundamental to its utility in medicine, underscoring the importance of meticulous sourcing and quality assurance in the pharmaceutical sector.